Escherichia coli is the most common organism associated with asymptomatic bacteriuria (ABU). In contrast to uropathogenic E. coli (UPEC), which causes symptomatic urinary tract infection (UTI), very little is known about the mechanisms by which these strains colonize the urinary tract. Bacterial adhesion conferred by specific surface-associated adhesins is normally considered as a prerequisite for colonization of the urinary tract. The prototype ABU E. coli strain 83972 was originally isolated from a girl who had carried it asymptomatically for 3 years. This study characterized the molecular status of one of the primary adhesion factors known to be associated with UTI, namely F1C fimbriae, encoded by the foc gene cluster. F1C fimbriae recognize receptors present in the human kidney and bladder. Expression of the foc genes was found to be up-regulated in human urine. It was also shown that although strain 83972 contains a seemingly intact foc gene cluster, F1C fimbriae are not expressed. Sequencing and genetic complementation revealed that the focD gene, encoding a component of the F1C transport and assembly system, was non-functional, explaining the inability of strain 83972 to express this adhesin. The data imply that E. coli 83972 has lost its ability to express this important colonization factor as a result of host-driven evolution. The ancestor of the strain seems to have been a pyelonephritis strain of phylogenetic group B2. Strain 83972 therefore represents an example of bacterial adaptation from pathogenicity to commensalism through virulence factor loss.
BachmannB. J.
others1996; Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn. pp 2460–2488 Edited by
NeidhardtF. C.
Washington, DC: American Society for Microbiology;
BäckhedF,
AlsenB, RocheN, AngstromJ, BreimerM. E, Westerlund-WikstromB, TenebergS, Richter-DahlforsA,
von EulerA. 2002; Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J Biol Chem 277:18198–18205[CrossRef]
DarouicheR. O, DonovanW. H, Del TerzoM, ThornbyJ. I, RudyD. C, HullR. A.
2001; Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58:339–344[CrossRef]
DatsenkoK. A, WannerB. L.
2000; One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645[CrossRef]
EdenC. S, HansonL. A, JodalU, LindbergU, AkerlundA. S.
1976; Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet 1:490–492
HullR. A, RudyD. C, DonovanW. H, WieserI. E, StewartC, DarouicheR. O.
1999; Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 67:429–432
KlemmP, ChristiansenG, KreftB, MarreR, BergmansH.
1994; Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol 176:2227–2234
KlemmP, JorgensenB. J, KreftB, ChristiansenG.
1995; The export systems of type 1 and F1C fimbriae are interchangeable but work in parental pairs. J Bacteriol 177:621–627
KlemmP, RoosV, UlettG. C, SvanborgC, SchembriM. A.
2006; Molecular characterisation of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 74:781–785[CrossRef]
LiC, WongW. H.
2001; Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98:31–36[CrossRef]
MulveyM. A, Lopez-BoadoY. S, WilsonC. L, RothR, ParksW. C, HeuserJ, HultgrenS. J.
1998; Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli . Science 282:1494–1497[CrossRef]
OrskovI, Svanborg EdenC, OrskovF.
1988; Aerobactin production of serotyped Escherichia coli from urinary tract infections. Med Microbiol Immunol 177:9–14
OttM, JannK, HackerJ,
HoschützkyH,
van DieI. 1988; Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli : comparative aspects of structure and function. J Bacteriol 170:3983–3990
PereA, NowickiB, SaxenH, SiitonenA, KorhonenT. K.
1987; Expression of P, type 1, and type 1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis 156:567–574[CrossRef]
PlosK, CarterT, HullS, HullR, Svanborg EdenC.
1990; Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli . J Infect Dis 161:518–524[CrossRef]
PlosK, ConnellH, JodalU, MarklundB. I, MarildS, WettergrenB, SvanborgC.
1995; Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 171:625–631[CrossRef]
SiitonenA, MartikainenR, PalmgrenJ,
IkäheimoR,
MäkeläP. H. 1993; Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation. Microb Pathog 15:65–75[CrossRef]
SnyderJ. A, HaugenB. J, LockatellC. V, MaroncleN, HaganE. C, JohnsonD. E, WelchR. A, MobleyH. L. T.
2005; Coordinate expression of fimbriae in uropathogenic Escherichia coli . Infect Immun 73:7588–7596[CrossRef]
SokurenkoE. V, CourtneyH. S, OhmanD. E, KlemmP, HastyD. L.
1994; FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol 176:748–755
SokurenkoE. V, CourtneyH. S, MaslowJ, SiitonenA, HastyD. L.
1995; Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 177:3680–3686
TrautnerB. W, DarouicheR. O, HullR. A, HullS, ThornbyJ. I.
2002; Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis . J Urol 167:375–379[CrossRef]
TrautnerB. W, HullR. A, DarouicheR. O.
2003; Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 61:1059–1062[CrossRef]
van DieI,
van GeffenB,
HoekstraW, BergmansH.
1985; Type 1C fimbriae of a uropathogenic Escherichia coli strain: cloning and characterization of the genes involved in the expression of the 1C antigen and nucleotide sequence of the subunit gene. Gene 34:187–196[CrossRef]
WelchR. A, BurlandV,
PlunkettG., 3rd.
16 other authors2002; Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli . Proc Natl Acad Sci U S A 99:17020–17024[CrossRef]
WulltB.
2003; The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 21:605–621[CrossRef]
WulltB, BergstenG, ConnellH, RollanoP, GebretsadikN, HullR, SvanborgC.
2000; P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 38:456–464[CrossRef]